18 completed, 3 unknown. 21 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 21 | Completed 18, Unknown 3 |
Follow Pasteurellaceae Infections: new trials by email Literature Review of Pasteurellaceae Infections trials Research Report on Pasteurellaceae Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study) Vaxelis, PedvaxHIB - Haemophilus Influenzae Type B Infection | Phase 4 | Completed | Johns Hopkins Bloomberg School of Public Health | 333 | 2022-01-27 | 2024-06-24 |
| A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal 13-valent conjugate vaccine - Diphtheria | Phase 4 | Completed | GlaxoSmithKline | 500 | 2021-05-26 | 2024-08-27 |
| A Phase IV Study to Assess the Safety of EupentaTM Inj Eupenta Inj. - Hepatitis B, Diphtheria | Phase 4 | Unknown | LG Chem | 3000 | 2019-09-23 | 2019-08-14 |
| Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Infanrix hexa - Diphtheria, Hepatitis B | Phase 4 | Completed | GlaxoSmithKline | 551 | 2016-09-19 | 2020-01-14 |
| Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age Meningococcal polysaccharide diphtheria toxoid conjugate, Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate - Meningitis, Meningococcal Infection | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 1394 | 2012-07-01 | 2015-12-15 |
| Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children Haemophilus influenza type b conjugate vaccine - Haemophilus Influenzae Type B Infection | Phase 4 | Completed | Novartis Vaccines | 764 | 2011-08-01 | 2016-12-01 |
| Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ Blood Sampling - Tetanus, Poliomyelitis | Phase 4 | Completed | GlaxoSmithKline | 58 | 2011-05-30 | 2021-01-19 |
| Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination Quinvaxem, Quinvaxem/Tritanrix - Diphtheria, Pertussis | Phase 4 | Completed | Crucell Holland BV | 400 | 2011-05-01 | 2013-09-09 |
| Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine Shan 5 - Diphtheria, Tetanus | Phase 4 | Unknown | Shantha Biotechnics Limited | 3000 | 2009-01-01 | 2009-05-06 |
| Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants Infanrix™ hexa - Hepatitis B, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 224 | 2008-09-23 | 2019-11-27 |
| Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine Shan5 - Diphtheria, Tetanus | Phase 4 | Completed | Shantha Biotechnics Limited | 160 | 2008-03-01 | 2009-06-25 |
| Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine Shan 5, Easy Five - Diphtheria, Tetanus | Phase 4 | Completed | Shantha Biotechnics Limited | 144 | 2008-03-01 | 2009-06-25 |
| Middle Meatal Bacteriology During Acute Respiratory Infection in Children placebo, amoxicillin clavulanate acid - Acute Respiratory Infection, Sinusitis | Phase 4 | Unknown | Oulu University Hospital | 120 | 2007-11-01 | 2007-10-19 |
| Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine Menitorix, Infanrix IPV - Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 4 | Completed | GlaxoSmithKline | 288 | 2007-05-16 | 2020-06-16 |
| Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib Vac - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi | 186 | 2005-12-01 | 2012-04-16 |
| Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants GSK Biologicals' combined DTPa-IPV/Hib vaccine - Diphtheria, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 2590 | 2004-11-02 | 2020-01-02 |
| Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®) - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 989 | 2004-02-01 | 2016-04-14 |
| Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccine - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi | 387 | 2003-10-01 | 2012-04-16 |
| Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course DTPa-HBV-IPV/Hib Vaccine (INFANRIX™ HEXA), DTPa-HBV-IPV-Hib vaccine (HEXAVAC™) - Hepatitis B, Poliomyelitis | Phase 4 | Completed | GlaxoSmithKline | 494 | 2003-10-01 | 2016-08-05 |
| The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine Hib conjugate vaccine - Haemophilus Influenzae Type b | Phase 4 | Completed | Public Health England | 2003-04-01 | 2018-08-24 |
Showing 20 of 21. Sign in to see all of them.
Haemophilus Infections (21) · Diphtheria (15) · Tetanus (15) · Hepatitis B (10) · Whooping Cough (10) · Poliomyelitis (8) · Meningitis (1) · Meningococcal Infections (1) · Respiratory Tract Infections (1) · Rhinosinusitis (1) · Sinusitis (1) · Virus Diseases (1)
Bacterial Infections (21) · Bacterial Infections and Mycoses (21) · Gram-Negative Bacterial Infections (21) · Infections (21) · Actinomycetales Infections (15) · Clostridium Infections (15) · Corynebacterium Infections (15) · Gram-Positive Bacterial Infections (15) · Virus Diseases (13) · Respiratory Tract Diseases (11) · Blood-Borne Infections (10) · Bordetella Infections (10) · Communicable Diseases (10) · DNA Virus Infections (10)
Tetanus Toxoid (4) · Pentavac (2) · Vaxelis (2) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (2) · 13-valent pneumococcal vaccine (1) · Blood Specimen Collection (1) · Diphtheria-Tetanus-acellular Pertussis Vaccines (1) · Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine (1) · Hexavac (1) · HibTITER protein, Haemophilus influenzae (1) · Meningococcal Vaccines (1) · Methods (1) · pentacel (1)
GlaxoSmithKline (7) · Shantha Biotechnics Limited (3) · Sanofi (2) · Sanofi Pasteur, a Sanofi Company (2) · Centers for Disease Control and Prevention (1) · Crucell Holland BV (1) · Johns Hopkins Bloomberg School of Public Health (1) · LG Chem (1) · Novartis Vaccines (1) · Oulu University Hospital (1) · Public Health England (1)
United States (4) · Finland (3) · India (3) · Italy (3) · Canada (2) · Philippines (2) · Spain (2) · Sweden (2) · Australia (1) · Czechia (1) · Germany (1) · Norway (1) · Poland (1) · Puerto Rico (1) · Singapore (1)
Raman Rao, MD (3) · Aila Kristo, MD (1) · Anna Marttila, MD (1) · Elizabeth Miller, MBBS FRCPath (1) · Jukka-Pekka Kuusiniemi, MD (1) · Laura Hammitt, MD (1) · Maria RZ Capeding, MD (1) · Olli-Pekka Alho, professor (1) · Thomas W Hennessy, MD,MPH (1) · Ulla Lantto, MD (1)
PMID 17699835, PMID 24176498, PMID 33612341
2014 (1), 2015 (1), 2019 (1)